Moderna, Inc. — Director's Dealing 2020

Jun 4, 2020

SEC Form 4/A — Form 4/A

Issuer: Moderna, Inc. (MRNA)
CIK: 0001682852
Period of Report: 2020-05-15

Reporting Person: Bancel Stephane (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-05-15	Common Stock	G	1577	—	Disposed	6739044	Direct

Footnotes

F1: The reported disposition was effected pursuant to a Rule 10b5-1 trading plan adopted on September 16, 2019.

F2: The reported disposition represents a bona fide charitable gift made by the reporting person.